Morphic Therapeutic, Inc. (a Wholly Owned Subsidiary Of Eli Lilly And Company)
Clinical trials sponsored by Morphic Therapeutic, Inc. (a Wholly Owned Subsidiary Of Eli Lilly And Company), explained in plain language.
-
New hope for Crohn's patients: experimental drug trial seeks to tame inflammation
Disease control Recruiting nowThis study is testing an experimental medication called MORF-057 for adults with moderate to severe Crohn's disease. It aims to see if the drug can reduce intestinal inflammation and improve symptoms better than a placebo. Participants will receive either the study drug or a plac…
Phase: PHASE2 • Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
First humans test new drug in early safety trial
Knowledge-focused Recruiting nowThis is the first study to test a new drug called MORF-440 in people. It will enroll 80 healthy volunteers to check if the drug is safe and how the body handles it. Researchers will give different doses to small groups and closely monitor for any side effects.
Phase: PHASE1 • Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:21 UTC